Ulcerative Colitis Phase II Study of GSK2831781 Discontinued

By Dr. Matthew Watson

Immutep’s Collaboration and Exclusive License with GSK Remains in Place Immutep’s Collaboration and Exclusive License with GSK Remains in Place

See the original post here:
Ulcerative Colitis Phase II Study of GSK2831781 Discontinued

Related Post


categoriaGlobal News Feed commentoComments Off on Ulcerative Colitis Phase II Study of GSK2831781 Discontinued | dataJanuary 22nd, 2021

About...

This author published 3712 posts in this site.

Share

FacebookTwitterEmailWindows LiveTechnoratiDeliciousDiggStumbleponMyspaceLikedin

Comments are closed.





Personalized Gene Medicine | Mesenchymal Stem Cells | Stem Cell Treatment for Multiple Sclerosis | Stem Cell Treatments | Board Certified Stem Cell Doctors | Stem Cell Medicine | Personalized Stem Cells Therapy | Stem Cell Therapy TV | Individual Stem Cell Therapy | Stem Cell Therapy Updates | MD Supervised Stem Cell Therapy | IPS Stem Cell Org | IPS Stem Cell Net | Genetic Medicine | Gene Medicine | Longevity Medicine | Immortality Medicine | Nano Medicine | Gene Therapy MD | Individual Gene Therapy | Affordable Stem Cell Therapy | Affordable Stem Cells | Stem Cells Research | Stem Cell Breaking Research